These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8294111)

  • 41. Genetic deficiency in alpha 1 proteinase inhibitor (alpha 1 PI) associated with emphysema.
    Martorana PA; Lungarella G
    Lab Anim Sci; 1998 Oct; 48(5):460-2. PubMed ID: 10090058
    [No Abstract]   [Full Text] [Related]  

  • 42. Angiogenesis and apoptosis are cellular parameters of neoplastic progression in transgenic mouse models of tumorigenesis.
    Bergers G; Hanahan D; Coussens LM
    Int J Dev Biol; 1998; 42(7):995-1002. PubMed ID: 9853830
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatic fibrosis and carcinogenesis in α1-antitrypsin deficiency: a prototype for chronic tissue damage in gain-of-function disorders.
    Perlmutter DH; Silverman GA
    Cold Spring Harb Perspect Biol; 2011 Mar; 3(3):. PubMed ID: 21421920
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular pathogenesis of alpha-1-antitrypsin deficiency-associated liver disease: a meeting review.
    Perlmutter DH; Brodsky JL; Balistreri WF; Trapnell BC
    Hepatology; 2007 May; 45(5):1313-23. PubMed ID: 17464974
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Significance of glycoproteins and lectins in gastroenterology and hepatology].
    Gerok W
    Z Gastroenterol Verh; 1985 Apr; 20():90-9. PubMed ID: 2409708
    [No Abstract]   [Full Text] [Related]  

  • 46. Analysis of intrahepatic lymphocyte subsets in a transgenic mouse model of immune-mediated hepatocarcinogenesis.
    Nakamoto Y; Kaneko S
    J Exp Clin Cancer Res; 2006 Mar; 25(1):55-7. PubMed ID: 16761618
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Does the concentration of alpha 1-proteinase inhibitor reflect the transformation of liver cirrhosis to liver carcinoma?
    Dabrowska M; Mantur M; Panasiuk A; Prokopowicz J
    Neoplasma; 1997; 44(5):305-7. PubMed ID: 9473790
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Calculation of the cumulative distribution function of the time to a small observable tumor.
    Sherman CD; Portier CJ
    Bull Math Biol; 2000 Mar; 62(2):229-40. PubMed ID: 10824428
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lack of p53 accelerates hepatocarcinogenesis in transgenic mice constitutively overexpressing c-myc in the liver.
    Klocke R; Bartels T; Jennings G; Brand K; Halter R; Strauss M; Paul D
    FASEB J; 2001 Jun; 15(8):1404-6. PubMed ID: 11387238
    [No Abstract]   [Full Text] [Related]  

  • 50. Hepatocellular carcinoma in transgenic mice: a consequence of continued expression of the HBx gene?
    Koff RS
    Gastroenterology; 1992 Mar; 102(3):1081-2. PubMed ID: 1371486
    [No Abstract]   [Full Text] [Related]  

  • 51. alpha1-Antitrypsin deficiency and hepatocellular cancer.
    Kew MC; Turnbull R; Prinsloo I
    Br J Cancer; 1978 Apr; 37(4):635-8. PubMed ID: 206274
    [No Abstract]   [Full Text] [Related]  

  • 52. [Hepatic neoductules].
    Fischer HP; Meybehm M; Zhou H; Schoch J
    Verh Dtsch Ges Pathol; 1995; 79():36-46. PubMed ID: 8600693
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatitis B injury, male gender, aflatoxin, and p53 expression each contribute to hepatocarcinogenesis in transgenic mice.
    Ghebranious N; Sell S
    Hepatology; 1998 Feb; 27(2):383-91. PubMed ID: 9462635
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Biliary epithelium, hepatocytes and oval cells].
    Housset C
    Rev Prat; 2000 Dec; 50(19):2106-11. PubMed ID: 11213452
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Does hepatitis C have a direct oncogenic effect?].
    Scoazec JY
    Gastroenterol Clin Biol; 1998 Dec; 22(12):1120-1. PubMed ID: 10051997
    [No Abstract]   [Full Text] [Related]  

  • 56. [Hepatocellular carcinoma animal models].
    Moriya K; Miyoshi H; Koike K
    Nihon Rinsho; 2015 Dec; 73 Suppl 9():74-8. PubMed ID: 26845908
    [No Abstract]   [Full Text] [Related]  

  • 57. [Does the association of liver carcinoma and alpha-1-antitryptin deficiency exist? Does it have a diagnostic significance?].
    Beaugrand M; Garnier JP; Ferrier JP; Buffet C; Vercaigne D; Martin JP
    Nouv Presse Med; 1978 Mar; 7(11):939-40. PubMed ID: 205836
    [No Abstract]   [Full Text] [Related]  

  • 58. [Retention of non-dividing hepatocytes in growing mouse liver].
    Uryvaeva IV; Faktor VM
    Dokl Akad Nauk SSSR; 1979; 249(5):1225-7. PubMed ID: 230947
    [No Abstract]   [Full Text] [Related]  

  • 59. The effect of variations in LET and cell cycle on radiation hepatocarcinogenesis.
    Wiley AL; Vogel HH; Clifton KH
    Radiat Res; 1973 May; 54(2):284-93. PubMed ID: 4350045
    [No Abstract]   [Full Text] [Related]  

  • 60. Mechanisms by which TLR4 and endotoxin promote hepatocellular carcinoma require further investigation.
    Mencin A; Gwak GY; Schwabe RF
    Hepatology; 2011 Aug; 54(2):745; author reply 745-6. PubMed ID: 21563198
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.